×
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow up of two randomised controlled trials
EWER K.
Type
Journal article
Publisher
Wiley
Publication Date
2023-01-06T00:00:00+00:00